Memo Therapeutics ^Company

Memo Therapeutics AG is a company that specializes in antibody discovery and immune repertoire analysis. They use their MemoMAB\u2122 platform to create a unique and large antibody library that represents an individual's immune repertoire. This library is expected to contain a significant number of relevant and rare antibodies, which can be used in antibody lead discovery programs and collaborations.